Qual é o preço para Ocean Biomedical, Inc. (OCEAW)

O preço para Ocean Biomedical, Inc. (OCEAW) é $0.0298

Qual é a capitalização de mercado para Ocean Biomedical, Inc. (OCEAW)

A capitalização de mercado para Ocean Biomedical, Inc. (OCEAW) é $7.94M

Ocean Biomedical, Inc. (OCEAW) Preço e Capitalização de Mercado

Ocean Biomedical, Inc. is a biopharmaceutical enterprise primarily engaged in identifying and advancing novel therapeutic agents. Their research and development efforts span several key disease areas, including cancer, fibrotic conditions, infectious illnesses, and inflammatory disorders. The company's current development pipeline features both mono-specific and bi-specific humanized monoclonal antibodies (mAbs). These candidates are engineered to target Chi3l1 and are being investigated for treating non-small cell lung cancer and glioblastoma multiforme, a type of brain tumor. Furthermore, Ocean Biomedical is progressing a small molecule therapeutic designed to interact with Chit1, intended for individuals afflicted with Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. Their proprietary WPDS platform has generated three additional product candidates: a vaccine aimed at preventing malaria; a humanized monoclonal antibody treatment; and a small molecule treatment, with both malaria therapeutics specifically targeting the Plasmodium falciparum glutamic-acid-rich protein (PfGARP). The company is also developing a therapy for hospitalized patients suffering from COVID-19. Founded in 2019, Ocean Biomedical's operations are headquartered in Providence, Rhode Island.

Preço para OCEAW	Ativo B	Capitalização de mercado de B	Resultados
$20,471.19 $7.94M	NVDA	$5.452T	+68,695,177.10%
$16,859.56 $7.94M	AAPL	$4.490T	+56,575,590.16%
$15,629.40 $7.94M	GOOG	$4.162T	+52,447,559.69%
$13,804.28 $7.94M	MSFT	$3.676T	+46,322,990.53%
$10,637.78 $7.94M	AMZN	$2.833T	+35,697,143.17%

Preço para OCEAW

Ativo B

Capitalização de mercado de B

Resultados

$20,471.19 $7.94M